Michael L. Klowden
Independent DirectorMr. Michael L. Klowden, also known as Mike, serves as Director at Melanoma Research Alliance. He serves as Independent Director of NKGen Biotech, Inc. since September 2023. He served as the Chief Executive Officer of Milken Institute. Since guiding the Institute through its transition from a private foundation to a publicly supported charitable organization, Mr. Klowden has overseen the launch of major research initiatives, from tracking the development of China's nascent capital markets to estimating the cost of preventable chronic disease to the U.S. economy. During his tenure, the and President has expanded its use of Financial Innovations Labs, high-level workshops that convene multidisciplinary experts to solve specific economic, environmental and policy problems. He also provided leadership as the Institute established a major presence in Washington, D.C., with the founding of FasterCures / The Center for Accelerating Medical Solutions. In 2009, FasterCures launched the inaugural Partnering for Cures conference, a groundbreaking gathering that encourages streamlined collaboration between leading medical researchers, philanthropists, policymakers and the biopharmaceutical industry. Mr. Klowden joined the Milken Institute in 2001 from Jefferies Group Inc., a global investment bank and institutional securities firm. Prior to joining Jefferies, he was a senior partner at Morgan, Lewis & Bockius, an international law firm he helped expand to more than 1,000 attorneys. He served as the President of Milken Institute. In addition to serving as one of the four members of the firm's management committee and managing partner of the Los Angeles office, he was responsible for a sizable business and finance practice. Before that, he was a partner at Mitchell, Silberberg & Knupp, where he practiced business law and represented major clients in the entertainment industry. Mr. Klowden received a bachelor's degree from the University of Chicago, where he now serves as a trustee and a JD from Harvard Law School. He has served on numerous for-profit and charitable boards.
Positions
- Company NameNKGen Biotech, Inc.Stock CodeNKGNPositionIndependent DirectorRelated SecuritiesColleagues
- PYPaul Y. SongCEO & Chairman
- JAJames A. GrafInterim Chief Financial Officer
- YKYoonmi KangSVP of Technical Ops & Development
- YMYong Man KimChief Scientific Officer
- ICIrene ChangSVP, HR & Corporate Culture
- KDKathleen D. ScottIndependent Director
- ATAnthony T. RederMember of Scientific Advisory Board
- CBCraig BlackstoneMember of Scientific Advisory Board
